Posts tagged: genetically engineered food
The onslaught of commercials castigating Initiative 522, the genetically engineered food labeling measure on the November ballot, may be taking their toll.
A new survey by The Elway Poll shows support for I-522 has dropped precipitously in the last month. In September, about two-thirds of voters surveyed said they supported the measure, which requires many foods bought at the store to carry labels if they have genetically modified ingredients. Only about one voter in five opposed it.
In the latest poll, that support is down to 46 percent, and opposition up to 42 percent. With the poll's margin of error at 5 percent, that's a statistical tie. More concerning for supporters could be that it has dipped below 50 percent support, because undecided voters tend to vote No if they remain undecided at the point they must cast their ballots.
The Seattle Times broke down the Elway Poll numbers this week. King TV had similar results from a separate poll.
The latest Public Disclosure Commission reports show the No campaign, funded in large part by Monsanto, DuPont and large food and beverage companies contributing to the Grocery Manufacturers Association, have spent about $13.5 million. The Yes campaign, which has collected large amounts from some natural food and cosmetic product companies, but also has hundreds of small donations from Washington and around the country, has spent about $5.4 million.
The opening salvo in the battle over the proposal to label genetically modified foods includes ammunition that hit the mark last year in
Wrong on both counts, say supporters of Initiative 522. Pet food isn't covered by the initiative, but genetically modified meats, would have to be labeled – if they ever reach the local supermarket.
Each campaign can produce legal theories of the state’s complicated initiative case law to support their claims. The Yes campaign has mounted a response ad which the No campaign is actively rebutting.
The average voter might wonder whether it’s worth fighting about…
To continue reading this post, see a version of an ad, or to comment, continue inside the blog.